Phase 4 N=30 Benzocaine Versus Placebo Spray for Pain Relief at Hysterosalpingogram
Pain Relief · Analgesia
Primary: Change in Pain Score — 50.6; 70.4 mm — p=0.43
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=13 The Effects of Cannabinoid on Patients With Non-GERD Related Non Cardiac Chest Pain
Chest Pain
Primary: Frequency of Chest Pain Episodes — 1; 3 participants
Phase 4 N=60 The Effects of Nicotine on Cognition in Schizophrenia
Schizophrenia
Primary: Effects of Nicotine Patch Compared With Placebo in Non- Smokers With Schizophrenia and Control Groups on Attention Measured by the Continuous Performance Test Identical…
Phase 4 N=30 Effect of Methylnaltrexone on the PK/PD Profiles of Ticagrelor in Patients Treated With Morphine
Coronary Artery Disease
Primary: Platelet Reactivity Measured by VerifyNow P2Y12 — 130; 97 PRU — p=0.261
Phase 4 N=35 A Pilot Comparison of Short-course Nitrofurantoin in Females With Uncomplicated Bacterial Cystitis in the Emergency Department
Uncomplicated Bacterial Cystitis
Primary: Number of Participants With Clinical Cure at Day 7 — 13; 12 participants
Phase 4 N=407 NAVISTAR® THERMOCOOL® Catheter Post Approval Registry
Paroxysmal Atrial Fibrillation
Primary: The Percentage of Subjects Experiencing Primary Adverse Events Within Seven Days of the Ablation Procedure. — 3.2; 6.4 percentage of participants
Phase 4 N=17 Safety and Efficacy of Ingenol Mebutate 0.05% Gel When Used After Cryotherapy in the Hypertrophic Actinic Keratoses
Actinic Keratoses
Primary: Safety of Combination Therapy vs Cryotherapy Alone — 0; 0 Participants
Phase 4 N=28 Comparative Study of the Efficacy of SARNA Sensitive Lotion for Treatment of Uremic Itch in Adult Hemodialysis Patients
Pruritis
Primary: Investigator Global Assessment — 2.63; 2.32 units on a scale
Phase 4 N=455 Long-acting Beta Agonist Step Down Study
Asthma
Primary: Treatment Failure — 38; 39; 45 participants
Phase 4 N=24 A Bioequivalence Study of Cefadroxil Film Coated Tablets After A Single Oral Dose Administration to Healthy Subjects
Infections, Urinary Tract
Primary: Maximal Measured Plasma Concentration (Cmax) After a Single Dose — 28.18; 29.20 Microgram per milliliter
Phase 4 N=127 Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics
Psychotic Disorders
Primary: Body Mass Index (BMI) Z-score Change — 0.040; -0.112; -0.088 Z Score
Phase 4 N=50 Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method
Arrhythmia, Cardiac · Kidney Cancer · Surgery
Primary: Incidence of Perioperative Cardiac Arrhythmias Evaluated by a Continuous ECG Holter Monitoring in the Perioperative Period — 6; 6; 18; 16 Participants — p=0.3861
Phase 4 N=106 Efficacy of Losartan in Preventing Progression of COPD
COPD · Emphysema · Chronic Bronchitis
Primary: Change in Percent Emphysema on CT Scan — -0.32; 2.18 % Emphysema Whole Lung — p=0.06
Phase 4 N=129 Antidepressant Therapy in Treating Bipolar Type II Major Depression
Bipolar Disorder · Depression
Primary: Depressive Relapse — 3; 4 Participants
Phase 4 N=303 Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids
Asthma
Primary: Mean Change From Baseline in Morning Peak Expiratory Flow (PEF) Over 12 Weeks in Intent-to-treat (ITT) Population — 19.3; 26.9 Liters/Minute (L/min) — p=0.012